Would you have Cellulitis when you have Multiple Sclerosis?


Cellulitis is found among people with Multiple sclerosis, especially for people who are female, 50-59 old, take medication Avonex and have Multiple sclerosis. We study 1,792 people who have Cellulitis and Multiple sclerosis from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

You are not alone

Join a support group for people who have Multiple sclerosis and Cellulitis >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Multiple Sclerosis

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) can be treated by Copaxone, Avonex, Tysabri, Rebif, Baclofen (latest reports from 316,154 Multiple sclerosis patients)


Cellulitis (infection under the skin) has been reported by people with breathing difficulty, hypotension, rashes, renal failure acute, itching (latest reports from 27,666 Cellulitis patients).

On Aug, 28, 2016

1,792 people who have Multiple Sclerosis and Cellulitis are studied.

Number of reports submitted per year:

Would you have Cellulitis when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experience Cellulitis *:

  • female: 76.15 %
  • male: 23.85 %

Age of people who have Multiple Sclerosis and experience Cellulitis *:

  • 0-1: 0.06 %
  • 2-9: 0.06 %
  • 10-19: 0.0 %
  • 20-29: 2.12 %
  • 30-39: 10.98 %
  • 40-49: 23.96 %
  • 50-59: 37.74 %
  • 60+: 25.08 %

Severity if Multiple Sclerosis and experience Cellulitis *:

  • least: 100 %
  • moderate: 0.0 %
  • severe: 0.0 %
  • most severe: 0.0 %

Top co-existing conditions for these people *:

  • Multiple Sclerosis (1,792 people)
  • Hypertension (45 people)
  • Depression (39 people)
  • Pain (36 people)
  • Muscle Spasticity (20 people)
  • Osteoporosis (18 people)
  • Hypothyroidism (15 people)
  • Gastrooesophageal Reflux Disease (14 people)
  • Muscle Spasms (13 people)
  • Migraine (13 people)

Most common drugs for these people *:

  • Avonex (825 people)
  • Tysabri (603 people)
  • Rebif (226 people)
  • Baclofen (131 people)
  • Betaseron (92 people)
  • Gilenya (52 people)
  • Neurontin (42 people)
  • Lasix (36 people)
  • Provigil (35 people)
  • Lisinopril (34 people)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Cellulitis and Multiple sclerosis?

Browse all symptoms of Multiple sclerosis

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Cellulitis


Other conditions that could case Cellulitis


Can you answer these questions?

More questions for: Multiple sclerosis, Cellulitis

You may be interested in these reviews

More reviews for: Multiple sclerosis, Cellulitis

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.